B · Normal
[JD Health’s third quarter revenue was 20 billion yuan A year-on-year increase of 16.9%] On November 17, JD Health announced that in the third quarter of 2026, it achieved revenue of 20.017 billion yuan, a year-on-year increase of 16.9%; operating profit was 1.195 billion yuan, a year-on-year decrease of 3.9%; non- IFRS operating profit was 1.575 billion yuan, a year-on-year increase of 14.3%; profit during the period was 1.557 billion yuan, a year-on-year decrease of 15.3%; non-IFRS operating profit was 1.931 billion yuan, a year-on-year increase of 1.5%. In terms of business, as of September 30, more than 110 pharmaceutical companies have chosen JD Health as their new product launch partner; in the third quarter, more than 50 new drugs were launched online through JD Health. The average daily AI health service interaction volume of AI doctor "Dawei" increased by more than 5 times year-on-year.
Hong Kong stock trends 🕐 2026-11-17 17:01

Related telegraphs

Comments

0/500
Captcha (click to refresh)
No comments yet